Latest news
Nkarta reports Q2 EPS (54c), consensus (36c) - TipRanksTipRanks · Mon, 10 Aug 2026 21:28:06 GMTNkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 20:30:35 GMTPaul Hastings says one donor could supply the world's cell therapy needs — and the bottleneck is not the science - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 05:09:00 GMTCell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings|Business Of Biotech - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 10:35:55 GMTNkarta Inc (NKTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Wed, 05 Aug 2026 07:00:00 GMTNkarta Stock Price Forecast. Should You Buy NKTX? - StockInvest.usStockInvest.us · Fri, 31 Jul 2026 22:25:50 GMT